Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (801-810 of 932) with videos related to

Pageof 94
Sort By:
Molecular Cancer Therapeutics|December 11, 2012
Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cellsPuja Sapra, Marc Damelin, John Dijoseph, et al.
Circulation|May 27, 2021
Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: COAPT TrialSaibal Kar, Michael J Mack, JoAnn Lindenfeld, et al.
European Journal of Heart Failure|July 4, 2023
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|August 29, 2020
Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT TrialPaul A Grayburn, Anna Sannino, David J Cohen, et al.
American Heart Journal|November 20, 2023
Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysisEmily P Zeitler, Frederik Dalgaard, William T Abraham, et al.
European Journal of Heart Failure|September 6, 2023
Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trialsMarat Fudim, Frederik Dalgaard, Daniel J Friedman, et al.
Diabetes Care|September 29, 2004
The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational StudyAlan H B Wu, Torbjørn Omland, Philippe Duc, et al.
European Journal of Heart Failure|April 17, 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, João Pedro Ferreira, Jawad H Butt, et al.
Circulation. Heart Failure|August 8, 2020
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval StudyDavid M Shavelle, Akshay S Desai, William T Abraham, et al.
Pageof 94

Showing results (801-810 of 932) with videos related to

Sort By:
Pageof 94
Molecular Cancer Therapeutics|December 11, 2012
Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cellsPuja Sapra, Marc Damelin, John Dijoseph, et al.
Circulation|May 27, 2021
Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: COAPT TrialSaibal Kar, Michael J Mack, JoAnn Lindenfeld, et al.
European Journal of Heart Failure|July 4, 2023
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|August 29, 2020
Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT TrialPaul A Grayburn, Anna Sannino, David J Cohen, et al.
American Heart Journal|November 20, 2023
Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysisEmily P Zeitler, Frederik Dalgaard, William T Abraham, et al.
European Journal of Heart Failure|September 6, 2023
Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trialsMarat Fudim, Frederik Dalgaard, Daniel J Friedman, et al.
Diabetes Care|September 29, 2004
The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational StudyAlan H B Wu, Torbjørn Omland, Philippe Duc, et al.
European Journal of Heart Failure|April 17, 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, João Pedro Ferreira, Jawad H Butt, et al.
Circulation. Heart Failure|August 8, 2020
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval StudyDavid M Shavelle, Akshay S Desai, William T Abraham, et al.
Pageof 94